» Articles » PMID: 24134212

Simultaneous Dual Protein Labeling Using a Triorthogonal Reagent

Overview
Journal J Am Chem Soc
Specialty Chemistry
Date 2013 Oct 19
PMID 24134212
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Construction of heterofunctional proteins is a rapidly emerging area of biotherapeutics. Combining a protein with other moieties, such as a targeting element, a toxic protein or small molecule, and a fluorophore or polyethylene glycol (PEG) group, can improve the specificity, functionality, potency, and pharmacokinetic profile of a protein. Protein farnesyl transferase (PFTase) is able to site-specifically and quantitatively prenylate proteins containing a C-terminal CaaX-box amino acid sequence with various modified isoprenoids. Here, we describe the design, synthesis, and application of a triorthogonal reagent, 1, that can be used to site-specifically incorporate an alkyne and aldehyde group simultaneously into a protein. To illustrate the capabilities of this approach, a protein was enzymatically modified with compound 1 followed by oxime ligation and click reaction to simultaneously incorporate an azido-tetramethylrhodamine (TAMRA) fluorophore and an aminooxy-PEG moiety. This was performed with both a model protein [green fluorescent protein (GFP)] as well as a therapeutically useful protein [ciliary neurotrophic factor (CNTF)]. Next, a protein was enzymatically modified with compound 1 followed by coupling to an azido-bis-methotrexate dimerizer and aminooxy-TAMRA. Incubation of that construct with a dihydrofolate reductase (DHFR)-DHFR-anti-CD3 fusion protein resulted in the self-assembly of nanoring structures that were endocytosed into T-leukemia cells and visualized therein. These results highlight how complex multifunctional protein assemblies can be prepared using this facile triorthogonal approach.

Citing Articles

Targeted Drug Delivery by MMAE Farnesyl-Bioconjugated Multivalent Chemically Self-Assembled Nanorings Induces Potent Receptor-Dependent Immunogenic Cell Death.

Wang Y, Kilic O, Rozumalski L, Distefano M, Wagner C Bioconjug Chem. 2024; 35(5):582-592.

PMID: 38701361 PMC: 11633779. DOI: 10.1021/acs.bioconjchem.4c00004.


Bioorthogonal labeling and profiling of N6-isopentenyladenosine (i6A) modified RNA.

Li Y, Zhou H, Chen S, Li Y, Guo Y, Chen X Nucleic Acids Res. 2024; 52(6):2808-2820.

PMID: 38426933 PMC: 11014277. DOI: 10.1093/nar/gkae150.


Promiscuous Enzymes for Residue-Specific Peptide and Protein Late-Stage Functionalization.

Alexander A, Elshahawi S Chembiochem. 2023; 24(17):e202300372.

PMID: 37338668 PMC: 10496146. DOI: 10.1002/cbic.202300372.


Enzymatic Bioconjugation: A Perspective from the Pharmaceutical Industry.

Debon A, Siirola E, Snajdrova R JACS Au. 2023; 3(5):1267-1283.

PMID: 37234110 PMC: 10207132. DOI: 10.1021/jacsau.2c00617.


Site-specific dual encoding and labeling of proteins via genetic code expansion.

Bednar R, Karplus P, Mehl R Cell Chem Biol. 2023; 30(4):343-361.

PMID: 36977415 PMC: 10764108. DOI: 10.1016/j.chembiol.2023.03.004.


References
1.
Guo P . The emerging field of RNA nanotechnology. Nat Nanotechnol. 2010; 5(12):833-42. PMC: 3149862. DOI: 10.1038/nnano.2010.231. View

2.
Salgado E, Radford R, Tezcan F . Metal-directed protein self-assembly. Acc Chem Res. 2010; 43(5):661-72. PMC: 2873059. DOI: 10.1021/ar900273t. View

3.
Chen I, Ting A . Site-specific labeling of proteins with small molecules in live cells. Curr Opin Biotechnol. 2005; 16(1):35-40. DOI: 10.1016/j.copbio.2004.12.003. View

4.
Kim M, Kleckley T, Wiemer A, Holstein S, Hohl R, Wiemer D . Synthesis and activity of fluorescent isoprenoid pyrophosphate analogues. J Org Chem. 2004; 69(24):8186-93. DOI: 10.1021/jo049101w. View

5.
Prost L, Grim J, Tonelli M, Kiessling L . Noncarbohydrate glycomimetics and glycoprotein surrogates as DC-SIGN antagonists and agonists. ACS Chem Biol. 2012; 7(9):1603-8. PMC: 3509189. DOI: 10.1021/cb300260p. View